Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah(TM) (CTL019), for children and young adults with B-cell ALL that is refractory or has relapsed at least twice | Novartis - discu.eu

Linking pages

Negli Stati Uniti è stata approvata la prima terapia genica contro la leucemia - Il Post http://www.ilpost.it/2017/08/31/kymriah-terapia-genica-leucemia/ 29 comments
US approves first cancer drug to use patient's own cells – with $475,000 price tag | US healthcare | The Guardian https://www.theguardian.com/us-news/2017/aug/30/cancer-drug-kymriah-leukemia-novartis 28 comments
FDA announces first US gene therapy approval for cancer treatment | CNN http://www.cnn.com/2017/08/30/health/fda-first-gene-therapy-leukemia/index.html 7 comments

Related searches:

Search whole site: site:novartis.com

Search title: Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah(TM) (CTL019), for children and young adults with B-cell ALL that is refractory or has relapsed at least twice | Novartis

See how to search.

Submit link to: